Lilly, Novo Fall After Trump Touts Lower Ozempic Price

Eli Lilly & Co. and Novo Nordisk A/S shares fell in late trading after President Donald Trump said the price of the blockbuster diabetes drug Ozempic could come down to just $150 a month.